The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Resveratrol and Cardiovascular Diseases
Open accessAbstract
The increased incidence of cardiovascular diseases (CVDs) has stimulated research for substances that could improve cardiovascular health. Among them, resveratrol (RES), a polyphenolic compound notably present in grapes and red wine, has been involved in the “French paradox”. RES is known for its antioxidant and anti-inflammatory properties and for its ability to upregulate endothelial NO synthase (eNOS). RES was able to scavenge •OH/O2•− and peroxyl radicals, which can limit the lipid peroxidation processes. Moreover, in bovine aortic endothelial cells (BAEC) under glucose-induced oxidative stress, RES restored the activity of dimethylargininedimethylaminohydrolase (DDAH), an enzyme that degrades an endogenous inhibitor of eNOS named asymmetric dimethylarginine (ADMA). Thus, RES could improve •NO availability and decrease the endothelial dysfunction observed in diabetes. Preclinical studies have made it possible to identify molecular targets (SIRT-1, AMPK, Nrf2, NFκB…); however, there are limited human clinical trials, and difficulties in the interpretation of results arise from the use of high-dose RES supplements in research studies, whereas low RES concentrations are present in red wine. The discussions on potential beneficial effects of RES in CVDs (atherosclerosis, hypertension, stroke, myocardial infarction, heart failure) should compare the results of preclinical studies with those of clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Renaud, S., & de Lorgeril, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91277-f · Cited by 3,643
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320
Regulation of pgc-1α, a nodal regulator of mitochondrial biogenesis
Fernandez-Marcos, P. J., & Auwerx, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001917 · Cited by 1,237
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915
Boocock, D. J., Faust, G. E. S., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., Booth, T. D., Crowell, J. A., Perloff, M., Gescher, A. J., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0022 · Cited by 824
Laslett, L. J., Alagona, P., Clark, B. A., Drozda, J. P., Saldivar, F., Wilson, S. R., Poe, C., & Hart, M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.002 · Cited by 768
Absorption of three wine-related polyphenols in three different matrices by healthy subjects
Goldberg, D. M., Yan, J., & Soleas, G. J. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00397-1 · Cited by 683
Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., & Förstermann, U. (2002) · Circulation · doi:10.1161/01.cir.0000029925.18593.5c · Cited by 666
Lin, K. Y., Ito, A., Asagami, T., Tsao, P. S., Adimoolam, S., Kimoto, M., Tsuji, H., Reaven, G. M., & Cooke, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000027109.14149.67 · Cited by 651
Roy, S., Khanna, S., Hussain, S.-R. A., Biswas, S., Azad, A., Rink, C., Gnyawali, S., Shilo, S., Nuovo, G. J., & Sen, C. K. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp015 · Cited by 614
Resveratrol and health—A comprehensive review of human clinical trials
Smoliga, J. M., Baur, J. A., & Hausenblas, H. A. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100143 · Cited by 594
Resveratrol bioavailability and toxicity in humans
Cottart, C., Nivet‐Antoine, V., Laguillier‐Morizot, C., & Beaudeux, J. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900437 · Cited by 592
Barger, J. L., Kayo, T., Vann, J. M., Arias, E. B., Wang, J., Hacker, T. A., Wang, Y., Raederstorff, D., Morrow, J. D., Leeuwenburgh, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002264 · Cited by 580
Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
Guttilla, I. K., & White, B. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031427 · Cited by 560
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Bhatt, J. K., Thomas, S., & Nanjan, M. J. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.003 · Cited by 475
Resveratrol induces mitochondrial biogenesis in endothelial cells
Csiszar, A., Labinskyy, N., Pinto, J. T., Ballabh, P., Zhang, H., Losonczy, G., Pearson, K., de Cabo, R., Pacher, P., Zhang, C., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00368.2009 · Cited by 449
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Tomé-Carneiro, J., Larrosa, M., González-Sarrías, A., Tomás-Barberán, F., García-Conesa, M., & Espín, J. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990407 · Cited by 449
Leikert, J. F., Räthel, T. R., Wohlfart, P., Cheynier, V., Vollmar, A. M., & Dirsch, V. M. (2002) · Circulation · doi:10.1161/01.cir.0000034445.31543.43 · Cited by 424
Kennedy, D. O., Wightman, E. L., Reay, J. L., Lietz, G., Okello, E. J., Wilde, A., & Haskell, C. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28641 · Cited by 415
Su, H.-C., Hung, L.-M., & Chen, J.-K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00487.2005 · Cited by 412
Rivera, L., Morón, R., Zarzuelo, A., & Galisteo, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.027 · Cited by 391
Tomé-Carneiro, J., Larrosa, M., Yáñez-Gascón, M. J., Dávalos, A., Gil-Zamorano, J., Gonzálvez, M., García-Almagro, F. J., Ruiz Ros, J. A., Tomás-Barberán, F. A., Espín, J. C., et al. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.03.011 · Cited by 378
Drug Interactions Due to Cytochrome P450
Ogu, C. C., & Maxa, J. L. (2000) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2000.11927719 · Cited by 370 · cited 1×
“The question of a RES-induced inhibition of CYP3A4 leads to possible interactions with medications used in CVDs, especially statins (HMG-CoA reductase inhibitors), calcium channel blockers and anti-arrhythmic agents [123].”
BackgroundMagyar, K., Halmosi, R., Palfi, A., Feher, G., Czopf, L., Fulop, A., Battyany, I., Sumegi, B., Toth, K., & Szabados, E. (2012) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2011-1424 · Cited by 364
Tanno, M., Kuno, A., Yano, T., Miura, T., Hisahara, S., Ishikawa, S., Shimamoto, K., & Horio, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.090266 · Cited by 358
Circulating MicroRNAs: Biomarkers or Mediators of Cardiovascular Diseases?
Fichtlscherer, S., Zeiher, A. M., & Dimmeler, S. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226696 · Cited by 339
Zordoky, B. N. M., Robertson, I. M., & Dyck, J. R. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.016 · Cited by 335
Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
Chow, H.-H. S., Garland, L. L., Hsu, C.-H., Vining, D. R., Chew, W. M., Miller, J. A., Perloff, M., Crowell, J. A., & Alberts, D. S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0155 · Cited by 330
Liu, K., Zhou, R., Wang, B., & Mi, M.-T. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.082024 · Cited by 323
Cardiovascular effects and molecular targets of resveratrol
Li, H., Xia, N., & Förstermann, U. (2012) · Nitric Oxide · doi:10.1016/j.niox.2011.12.006 · Cited by 287
Sulaiman, M., Matta, M. J., Sunderesan, N. R., Gupta, M. P., Periasamy, M., & Gupta, M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00418.2009 · Cited by 287
Wong, R. H. X., Howe, P. R. C., Buckley, J. D., Coates, A. M., Kunz, I., & Berry, N. M. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.03.003 · Cited by 277
Resveratrol: Preventing properties against vascular alterations and ageing
Delmas, D., Jannin, B., & Latruffe, N. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400098 · Cited by 269
Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway
Gurusamy, N., Lekli, I., Mukherjee, S., Ray, D., Ahsan, M. K., Gherghiceanu, M., Popescu, L. M., & Das, D. K. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp384 · Cited by 263
Beneficial action of resveratrol: How and why?
Diaz-Gerevini, G. T., Repossi, G., Dain, A., Tarres, M. C., Das, U. N., & Eynard, A. R. (2016) · Nutrition · doi:10.1016/j.nut.2015.08.017 · Cited by 260
Tomé-Carneiro, J., Gonzálvez, M., Larrosa, M., Yáñez-Gascón, M. J., García-Almagro, F. J., Ruiz-Ros, J. A., García-Conesa, M. T., Tomás-Barberán, F. A., & Espín, J. C. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.03.030 · Cited by 259
Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans
Cottart, C., Nivet‐Antoine, V., & Beaudeux, J. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200589 · Cited by 250
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt
Chan, A. Y. M., Dolinsky, V. W., Soltys, C.-L. M., Viollet, B., Baksh, S., Light, P. E., & Dyck, J. R. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802869200 · Cited by 244
Tomé-Carneiro, J., Gonzálvez, M., Larrosa, M., Yáñez-Gascón, M. J., García-Almagro, F. J., Ruiz-Ros, J. A., Tomás-Barberán, F. A., García-Conesa, M. T., & Espín, J. C. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6427-8 · Cited by 241
Saunders, L. R., Sharma, A. D., Tawney, J., Nakagawa, M., Okita, K., Yamanaka, S., Willenbring, H., & Verdin, E. (2010) · Aging · doi:10.18632/aging.100176 · Cited by 237
Popat, R., Plesner, T., Davies, F., Cook, G., Cook, M., Elliott, P., Jacobson, E., Gumbleton, T., Oakervee, H., & Cavenagh, J. (2013) · British Journal of Haematology · doi:10.1111/bjh.12154 · Cited by 226
miR‐20b modulates VEGF expression by targeting HIF‐1α and STAT3 in MCF‐7 breast cancer cells
Cascio, S., D'Andrea, A., Ferla, R., Surmacz, E., Gulotta, E., Amodeo, V., Bazan, V., Gebbia, N., & Russo, A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22126 · Cited by 222
Karlsen, A., Paur, I., Bøhn, S. K., Sakhi, A. K., Borge, G. I., Serafini, M., Erlund, I., Laake, P., Tonstad, S., & Blomhoff, R. (2010) · European Journal of Nutrition · doi:10.1007/s00394-010-0092-0 · Cited by 216
Bivalacqua, T. J., Hellstrom, W. J. G., Kadowitz, P. J., & Champion, H. C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4874 · Cited by 212
Herb–Drug Interactions: Challenges and Opportunities for Improved Predictions
Brantley, S. J., Argikar, A. A., Lin, Y. S., Nagar, S., & Paine, M. F. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055236 · Cited by 211
Tomé‐Carneiro, J., Gonzálvez, M., Larrosa, M., García‐Almagro, F. J., Avilés‐Plaza, F., Parra, S., Yáñez‐Gascón, M. J., Ruiz‐Ros, J. A., García‐Conesa, M. T., Tomás‐Barberán, F. A., et al. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100673 · Cited by 209
Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice
Dolinsky, V. W., Chakrabarti, S., Pereira, T. J., Oka, T., Levasseur, J., Beker, D., Zordoky, B. N., Morton, J. S., Nagendran, J., Lopaschuk, G. D., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.018 · Cited by 206
Arunachalam, G., Yao, H., Sundar, I. K., Caito, S., & Rahman, I. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.080 · Cited by 205
Bo, S., Ciccone, G., Castiglione, A., Gambino, R., De Michieli, F., Villois, P., Durazzo, M., Cavallo-Perin, P., & Cassader, M. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320100009 · Cited by 202
KAGA, S., ZHAN, L., MATSUMOTO, M., & MAULIK, N. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.08.003 · Cited by 199
Gepner, Y., Golan, R., Harman-Boehm, I., Henkin, Y., Schwarzfuchs, D., Shelef, I., Durst, R., Kovsan, J., Bolotin, A., Leitersdorf, E., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1650 · Cited by 196
Bagul, P. K., Middela, H., Matapally, S., Padiya, R., Bastia, T., Madhusudana, K., Reddy, B. R., Chakravarty, S., & Banerjee, S. K. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.05.003 · Cited by 193
Sahebkar, A. (2013) · Nutrition Reviews · doi:10.1111/nure.12081 · Cited by 192
Resveratrol-loaded polymeric micelles protect cells from Aβ-induced oxidative stress
Lu, X., Ji, C., Xu, H., Li, X., Ding, H., Ye, M., Zhu, Z., Ding, D., Jiang, X., Ding, X., et al. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.03.021 · Cited by 190
Faghihzadeh, F., Adibi, P., & Hekmatdoost, A. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002433 · Cited by 188
Singh, N., Agrawal, M., & Doré, S. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400094w · Cited by 183
Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old Rats
White, A. R., Ryoo, S., Li, D., Champion, H. C., Steppan, J., Wang, D., Nyhan, D., Shoukas, A. A., Hare, J. M., & Berkowitz, D. E. (2006) · Hypertension · doi:10.1161/01.hyp.0000198543.34502.d7 · Cited by 179
Hung, L.-M., Su, M.-J., & Chen, J.-K. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.12.016 · Cited by 178
Lekakis, J., Rallidis, L. S., Andreadou, I., Vamvakou, G., Kazantzoglou, G., Magiatis, P., Skaltsounis, A.-L., & Kremastinos, D. T. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200512000-00013 · Cited by 177
Pleiotropic mechanisms facilitated by resveratrol and its metabolites
Calamini, B., Ratia, K., Malkowski, M. G., Cuendet, M., Pezzuto, J. M., Santarsiero, B. D., & Mesecar, A. D. (2010) · Biochemical Journal · doi:10.1042/bj20091857 · Cited by 175
Resveratrol Levels and All-Cause Mortality in Older Community-Dwelling Adults
Semba, R. D., Ferrucci, L., Bartali, B., Urpí-Sarda, M., Zamora-Ros, R., Sun, K., Cherubini, A., Bandinelli, S., & Andres-Lacueva, C. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1582 · Cited by 168
Wightman, E. L., Reay, J. L., Haskell, C. F., Williamson, G., Dew, T. P., & Kennedy, D. O. (2014) · British Journal of Nutrition · doi:10.1017/s0007114514000737 · Cited by 168
Calorie restriction and resveratrol in cardiovascular health and disease
Dolinsky, V. W., & Dyck, J. R. B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.010 · Cited by 168
Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia
Huang, S. S., Tsai, M. C., Chih, C. L., Hung, L. M., & Tsai, S. K. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01195-x · Cited by 167
Gresele, P., Pignatelli, P., Guglielmini, G., Carnevale, R., Mezzasoma, A. M., Ghiselli, A., Momi, S., & Violi, F. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.9.1602 · Cited by 166
Berrougui, H., Grenier, G., Loued, S., Drouin, G., & Khalil, A. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.017 · Cited by 161
Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials
Liu, Y., Ma, W., Zhang, P., He, S., & Huang, D. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.03.009 · Cited by 161
Militaru, C., Donoiu, I., Craciun, A., Scorei, I. D., Bulearca, A. M., & Scorei, R. I. (2013) · Nutrition · doi:10.1016/j.nut.2012.07.006 · Cited by 161
The controversial world of sirtuins
Dang, W. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.08.003 · Cited by 158
Kanamori, H., Takemura, G., Goto, K., Tsujimoto, A., Ogino, A., Takeyama, T., Kawaguchi, T., Watanabe, T., Morishita, K., Kawasaki, M., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.009 · Cited by 157
Frombaum, M., Clanche, S. L., Bonnefont‐Rousselot, D., & Borderie, D. (2011) · Biochimie · doi:10.1016/j.biochi.2011.11.001 · Cited by 157
Self-citationDrug interaction potential of resveratrol
Detampel, P., Beck, M., Krähenbühl, S., & Huwyler, J. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.700715 · Cited by 154
Rimbaud, S., Ruiz, M., Piquereau, J., Matéo, P., Fortin, D., Veksler, V., Garnier, A., & Ventura‐Clapier, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026391 · Cited by 154
Carrizzo, A., Puca, A. A., Damato, A., Marino, M., Franco, E., Pompeo, F., Traficante, A., Civitillo, F., Santini, L., Trimarco, V., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.01009 · Cited by 145
Chang, T. K. H., Chen, J., & Lee, W. B. K. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29205-3 · Cited by 145
Metabolites and tissue distribution of resveratrol in the pig
Azorín‐Ortuño, M., Yáñez-Gascón, M. J., Vallejo, F., Pallarés, F. J., Larrosa, M., Lucas, R., Morales, J. C., Tomás-Barberán, F. A., García‐Conesa, M., & Espín, J. C. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100140 · Cited by 143
Agarwal, B., Campen, M. J., Channell, M. M., Wherry, S. J., Varamini, B., Davis, J. G., Baur, J. A., & Smoliga, J. M. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.027 · Cited by 137
Qin, F., Siwik, D. A., Luptak, I., Hou, X., Wang, L., Higuchi, A., Weisbrod, R. M., Ouchi, N., Tu, V. H., Calamaras, T. D., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.067801 · Cited by 137
Das, S., Cordis, G. A., Maulik, N., & Das, D. K. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00453.2004 · Cited by 133
van der Made, S. M., Plat, J., & Mensink, R. P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118393 · Cited by 131
Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters.
Cho, I.-J., Ahn, J., Kim, S., Choi, M.-S., & Ha, T. (2008) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2007.12.140 · Cited by 130
Fujitaka, K., Otani, H., Jo, F., Jo, H., Nomura, E., Iwasaki, M., Nishikawa, M., Iwasaka, T., & Das, D. K. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.09.028 · Cited by 129
Fukuda, S., Kaga, S., Zhan, L., et al. (2006) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:44:1:043 · Cited by 129
Wan, D., Zhou, Y., Wang, K., Hou, Y., Hou, R., & Ye, X. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.02.011 · Cited by 129
Lindner, G. D. R., Santos, D. B., Colle, D., Moreira, E. L. G., Prediger, R. D., Farina, M., Khalil, N. M., & Mainardes, R. M. (2015) · Nanomedicine · doi:10.2217/nnm.14.165 · Cited by 127
Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure
Gu, X. S., Wang, Z., Ye, Z., Lei, J., Li, L., Su, D., & Zheng, X. (2014) · Genetics and Molecular Research · doi:10.4238/2014.january.17.17 · Cited by 125
Zhang, H., Morgan, B., Potter, B. J., Ma, L., Dellsperger, K. C., Ungvari, Z. I., & Zhang, C. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00489.2010 · Cited by 122
Park, D., Baek, K., Kim, J.-R., Lee, J. J., Ryu, S.-H., Chin, B.-R., & Baek, S. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.3.020 · Cited by 121
Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation
Latruffe, N., Lançon, A., Frazzi, R., Aires, V., Delmas, D., Michaille, J., Djouadi, F., Bastin, J., & Cherkaoui‐Malki, M. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12819 · Cited by 119
Potential of resveratrol in the treatment of heart failure
Raj, P., Louis, X. L., Thandapilly, S. J., Movahed, A., Zieroth, S. R., & Netticadan, T. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.12.011 · Cited by 118
Rush, J. W. E., Quadrilatero, J., Levy, A. S., & Ford, R. J. (2007) · Experimental Biology and Medicine · doi:10.3181/00379727-232-2320814 · Cited by 116
Resveratrol Alleviates Endotoxin-Induced Myocardial Toxicity via the Nrf2 Transcription Factor
Hao, E., Lang, F., Chen, Y., Zhang, H., Cong, X. Y., Shen, X., & Su, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069452 · Cited by 110
Anti-atherogenic effects of resveratrol
Ramprasath, V. R., & Jones, P. J. H. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.77 · Cited by 103
Erythropoietin Increases Asymmetric Dimethylarginine in Endothelial Cells
Scalera, F., Kielstein, J. T., Martens‐Lobenhoffer, J., Postel, S. C., Diaeresis]ger, M. T., & Bode‐Böger, S. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090735 · Cited by 97
Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals
Neves, A. R., Martins, S., Segundo, M. A., & Reis, S. (2016) · Nutrients · doi:10.3390/nu8030131 · Cited by 97
Resveratrol and cardiovascular health – Promising therapeutic or hopeless illusion?
Tang, P. C., Ng, Y.-F., Ho, S., Gyda, M., & Chan, S. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.08.001 · Cited by 95
Zamora‐Ros, R., Urpí-Sardà, M., Lamuela-Raventós, R. M., Estruch, R., Vázquez-Agell, M., Serrano-Martínez, M., Jaeger, W., & Andrés‐Lacueva, C. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.065870 · Cited by 94
Cao, X., Luo, T., Luo, X., & Tang, Z. (2014) · Hypertension Research · doi:10.1038/hr.2014.90 · Cited by 88
Deng, Y., Alex, D., Huang, H., Wang, N., Yu, N., Wang, Y., Leung, G., & Lee, S. M. (2010) · Phytotherapy Research · doi:10.1002/ptr.3279 · Cited by 87
Protection against Recurrent Stroke with Resveratrol: Endothelial Protection
Clark, D., Tuor, U. I., Thompson, R. J., Institóris, Á., Kulynych, A. D., Zhang, X., Kinniburgh, D. W., Bari, F., Busija, D. W., & Barber, P. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047792 · Cited by 86
Rakici, O., Kızıltepe, U., Coskun, B., Aşlamacı, S., & Akar, F. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.01.013 · Cited by 86
Yashiro, T., Nanmoku, M., Shimizu, M., Inoue, J., & Sato, R. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.006 · Cited by 85
Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats
Chan, V., Fenning, A. S., Iyer, A., Hoey, A. J., & Brown, L. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794480552 · Cited by 84
Restoration of Altered MicroRNA Expression in the Ischemic Heart with Resveratrol
Mukhopadhyay, P., Mukherjee, S., Ahsan, M. K., Bagchi, A., Pacher, P., & Das, D. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015705 · Cited by 82
The two faces of hypertension: role of aortic stiffness
Smulyan, H., Mookherjee, S., & Safar, M. E. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.11.012 · Cited by 82
Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies
Turan, B., Tuncay, E., & Vassort, G. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9429-0 · Cited by 79
Yu, C., Shin, Y. G., Kosmeder, J. W., Pezzuto, J. M., & van Breemen, R. B. (2003) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.918 · Cited by 79
Zamora‐Ros, R., Urpí-Sardà, M., Lamuela-Raventós, R. M., Martínez‐González, M. Á., Salas‐Salvadó, J., Arós, F., Fitó, M., Lapetra, J., Estruch, R., & Andrés‐Lacueva, C. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.03.009 · Cited by 79
Gordish, K. L., & Beierwaltes, W. H. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00437.2013 · Cited by 78
Hormetic response of resveratrol against cardioprotection.
Juhász, B., Mukherjee, S., & Das, D. K. (2010) · Europe PMC (PubMed Central) · Cited by 71
Shen, M., Wu, R., Zhao, L., Li, J., Guo, H.-T., Fan, R., Cui, Y. R., Wang, Y., Yue, S., & Pei, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051223 · Cited by 71
Chen, Y.-R., Yi, F.-F., Li, X., Wang, C., Chen, L., Yang, X., Su, P., & Cai, J. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6141-8 · Cited by 70
Saad, M. I., Abdelkhalek, T. M., Saleh, M. M., Kamel, M. A. E.-N., Youssef, M., Tawfik, S. H., & Domínguez, H. (2015) · Endocrine · doi:10.1007/s12020-015-0709-4 · Cited by 67
Beaudoin, M., Perry, C. G. R., Arkell, A. M., Chabowski, A., Simpson, J. A., Wright, D. C., & Holloway, G. P. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.270538 · Cited by 67
Shalwala, M., Zhu, S., Das, A., Salloum, F. N., Xi, L., & Kukreja, R. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086977 · Cited by 66
Frombaum, M., Thérond, P., Djelidi, R., Beaudeux, J., Bonnefont‐Rousselot, D., & Borderie, D. (2011) · Free Radical Research · doi:10.3109/10715762.2010.527337 · Cited by 66
Self-citationBresciani, L., Calani, L., Bocchi, L., Delucchi, F., Savi, M., Ray, S., Brighenti, F., Stilli, D., & Rio, D. D. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.09.008 · Cited by 65
Huang, J., Huang, S., Deng, J.-Y., Chang, C., Day, Y., & Hung, L. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.08.032 · Cited by 61
Arrick, D. M., Sun, H., Patel, K. P., & Mayhan, W. G. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00312.2011 · Cited by 61
Protective effect of resveratrol against pressure overload‐induced heart failure
Gupta, P., DiPette, D. J., & Supowit, S. C. (2014) · Food Science & Nutrition · doi:10.1002/fsn3.92 · Cited by 60
Multiple dietary supplements do not affect metabolic and cardiovascular health
Soare, A., Weiss, E. P., Holloszy, J. O., & Fontana, L. (2013) · Aging · doi:10.18632/aging.100597 · Cited by 60
Xuan, W., Wu, B., Chen, C., Chen, B., Zhang, W., Xu, D., Bin, J., & Liao, Y. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825fd7da · Cited by 58
Visioli, F. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.08.003 · Cited by 57
Lin, H., & Fast, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707231200 · Cited by 55
Acute responses to phytoestrogens in small arteries from men with coronary heart disease
Cruz, M. N., Luksha, L., Henareh, L., Poston, L., Agewall, S., & Kublickiene, K. R. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01065.2005 · Cited by 52
Dong, W., Yang, R., Yang, J. M., Yang, J., Ding, J., Wu, H., & Zhang, J. (2015) · PubMed · Cited by 51
Amri, A., Clanche, S. L., Thérond, P., Bonnefont‐Rousselot, D., Borderie, D., Lai–Kuen, R., Chaumeil, J., Sfar, S., & Charrueau, C. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.10.015 · Cited by 50
Self-citationRobich, M. P., Osipov, R. M., Chu, L. M., Han, Y., Feng, J., Nezafat, R., Clements, R., Manning, W. J., & Sellke, F. W. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.059 · Cited by 50
Söylemez, S., Sepici, A., & Akar, F. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6198-z · Cited by 49
Kucińska, M., PIOTROWSKA, H., Łuczak, M. W., Mikuła‐Pietrasik, J., Książek, K., Wozniak, M., Wierzchowski, M., Dudka, J., Jäger, W. R., & Murias, M. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.12.009 · Cited by 48
Göçmen, A. Y., Burgucu, D., & Gümüşlü, S. (2011) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h11-022 · Cited by 48
Thandapilly, S. J., Louis, X. L., Behbahani, J., Movahed, A., Yu, L., Fandrich, R. R., Zhang, S., Kardami, E., Anderson, H. D., & Netticadan, T. (2013) · Hypertension Research · doi:10.1038/hr.2013.55 · Cited by 47
Resveratrol prevents pathological but not physiological cardiac hypertrophy
Dolinsky, V. W., Soltys, C.-L. M., Rogan, K. J., Chan, A. Y. M., Nagendran, J., Wang, S., & Dyck, J. R. B. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1220-8 · Cited by 44
Yuan, Q., Peng, J., Liu, S., Wang, C., Xiang, D., Xiong, X., Hu, C., & Li, Y. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05368.x · Cited by 44
Louis, X. L., Thandapilly, S. J., Mohankumar, S. K., Yu, L., Taylor, C. G., Zahradka, P. C., & Netticadan, T. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.06.010 · Cited by 43
Haohao, Z., Guijun, Q., Juan, Z., Wen, K., & Lulu, C. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0392-1 · Cited by 42
Iwuchukwu, O. F., Tallarida, R. J., & Nagar, S. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.03.016 · Cited by 42
Endothelial Nrf2 activation: a new target for resveratrol?
Haskó, G., & Pacher, P. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00436.2010 · Cited by 42
Evans, H. M., Howe, P. R. C., & Wong, R. H. X. (2016) · Nutrients · doi:10.3390/nu8030150 · Cited by 42
Yin, K., Zhao, L., Feng, D., Ma, W., Liu, Y., Wang, Y., Liang, J., Yang, F., Bi, C., Chen, H., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374045 · Cited by 39
Resveratrol regulates autophagy signaling in chronically ischemic myocardium
Sabe, A. A., Elmadhun, N. Y., Dalal, R. S., Robich, M. P., & Sellke, F. W. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.06.062 · Cited by 37
MicroRNA signatures of resveratrol in the ischemic heart
Mukhopadhyay, P., Pacher, P., & Das, D. K. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05866.x · Cited by 35
Chain-breaking activity of resveratrol and piceatannol in a linoleate micellar model
Rhayem, Y., Thérond, P., Camont, L., Couturier, M., Beaudeux, J., Legrand, A., Jore, D., Gardès-Albert, M., & Bonnefont‐Rousselot, D. (2008) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2008.06.001 · Cited by 35
Self-citationDas, S., & Ng, K. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22212 · Cited by 33
Hobbs, T., Caso, R., McMahon, D., et al. (2015) · PubMed · Cited by 28
El‐Mowafy, A. M., Alkhalaf, M., & El‐Kashef, H. A. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.09.010 · Cited by 25
Radical-induced oxidation of trans-resveratrol
Camont, L., Collin, F., Couturier, M., Thérond, P., Jore, D., Gardès-Albert, M., & Bonnefont‐Rousselot, D. (2011) · Biochimie · doi:10.1016/j.biochi.2011.11.005 · Cited by 24
Self-citationAmadio, P., Baldassarre, D., Tarantino, E., Zacchi, E., Gianellini, S., Squellerio, I., Amato, M., Weksler, B. B., Tremoli, E., & Barbieri, S. S. (2015) · The FASEB Journal · doi:10.1096/fj.14-268383 · Cited by 17
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Cited by
Rudrapal, M., Khairnar, S. J., Khan, J., Dukhyil, A. B., Ansari, M. A., Alomary, M. N., Alshabrmi, F. M., Palai, S., Deb, P. K., & Devi, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.806470 · Cited by 1,084
Potential Adverse Effects of Resveratrol: A Literature Review
Shaito, A., Posadino, A. M., Younes, N., Hasan, H., Halabi, S., Alhababi, D., Al-Mohannadi, A., Abdel-Rahman, W. M., Eid, A. H., Nasrallah, G. K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062084 · Cited by 716
Polyphenols and their benefits: A review
Rasouli, H., Farzaei, M. H., & Khodarahmi, R. (2017) · International Journal of Food Properties · doi:10.1080/10942912.2017.1354017 · Cited by 476
Resveratrol and Its Effects on the Vascular System
Breuss, J. M., Atanasov, A. G., & Uhrin, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071523 · Cited by 328
Shen, C.-Y., Lu, C.-H., Wu, C.-H., Li, K.-J., Kuo, Y.-M., Hsieh, S.-C., & Yu, C.-L. (2020) · Molecules · doi:10.3390/molecules25235591 · Cited by 301
Metadata
- Authors
- Bonnefont-Rousselot, D.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2016-05-02
- Volume
- 8
- Issue
- 5
- Pages
- 250
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2345409531
- Cited by
- 442
- References
- 154
- FWCI
- 22.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.